Physician

Jessica Geimer Lucas, D.O.

According to 2025 Medicare claims, Jessica Lucas, D.O. (NPI: 1871719757) practices nephrology in the Wheeling, WV-OH market, with the plurality of this provider's patient population coming from Belmont, OH. This provider's primary affiliated billing organization is NEPHROLOGY ASSOCIATES, INC (NPI: 1457430134; TIN: 550667825) and primary practice location at 26003-6379. Lucas is affiliated with the ACO West Virginia (ACO ID: A3563), participating under the MSSP model.

Lucas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 370 traditional Medicare patients, billed 1,088 HCPCS/CPT codes, and received $125,875 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 1,367 prescription claims across 250 beneficiaries totaling $206,759 in drug costs, led by Lokelma (Sodium Zirconium Cyclosilicate). DME data shows 104 claims. Open Payments data shows 4 records totaling $37. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $252 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	448	1,287	$105,882
2016	485	1,468	$131,011
2017	486	1,590	$134,769
2018	460	2,268	$147,920
2019	503	2,454	$164,391
2020	451	1,827	$148,546
2021	398	1,615	$132,140
2022	381	1,559	$112,842
2023	356	1,582	$133,632
2024	370	1,088	$125,875

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	241	1,602	$207,137
2016	275	1,901	$230,032
2017	266	1,724	$181,995
2018	326	2,000	$181,715
2019	284	1,662	$156,917
2020	252	1,377	$92,421
2021	241	1,400	$123,333
2022	290	1,516	$149,037
2023	269	1,527	$172,180
2024	250	1,367	$206,759

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$326
2016	N/R	N/R	N/R
2017	N/R	11	$894
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	64	$5,388
2021	N/R	33	$4,336
2022	N/R	52	$3,804
2023	N/R	16	$201
2024	N/R	104	$2,231

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	48	115	$273
90961	Dialysis services, 2-3 physician visits per month (20 years or older)	30	42	$227
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	88	96	$133
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	111	392	$92
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	198	258	$90

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lokelma	Sodium Zirconium Cyclosilicate	41	2,407	$52,559
Farxiga	Dapagliflozin Propanediol	49	2,310	$43,676
Jardiance	Empagliflozin	37	2,243	$43,095
Veltassa	Patiromer Calcium Sorbitex	27	1,044	$35,739
Calcitriol	Calcitriol	187	9,432	$2,495

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7520	Sirolimus, oral, 1 mg	N	N/R	11	$563
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	13	$501
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	22	$376
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	27	$326
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	17	$249

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$37	AKEBIA THERAPEUTICS INC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jessica Geimer Lucas, D.O.?

Tedicare shows public-source Medicare data for Jessica Geimer Lucas, D.O. (NPI 1871719757), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jessica Geimer Lucas, D.O. have ACO affiliation data?

Jessica Geimer Lucas, D.O. is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563).

What billing organization is linked to Jessica Geimer Lucas, D.O.?

Jessica Geimer Lucas, D.O. is linked to NEPHROLOGY ASSOCIATES, INC (billing NPI 1457430134) in the available physician profile data.

Does Jessica Geimer Lucas, D.O. have Open Payments data?

Jessica Geimer Lucas, D.O. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.